Novo Nordisk (NVO) is upgraded to 'Hold' as its market cap returns to pre-GLP-1 mania levels, limiting further downside. NVO ...

Nvidia posted record $68.1 billion Q4 revenue and $43B net income, driven by data center AI demand, and guided $78B revenue ...

When you click on “Accept all”, you consent to ads on this site being customized to a personal profile we or our advertising partners may have about you. Choose “Customize or Reject all” if you want ...

Novo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and Rybelsus, by up to 50 percent beginning next year. Starting on Jan. 1, 2027, ...

SG&A expenses are expected to be in the range of $545 million to $565 million, and R&D expenses between $115 million and $135 million for 2026. Azamian reiterated the sales potential of XDEMVY as ...

Harmony Biosciences (NASDAQ:HRMY) reported fourth-quarter and full-year 2025 results highlighting continued growth for WAKIX and an expanding late-stage central nervous system (CNS) pipeline.

The failure of its next-generation obesity drug to match Eli Lilly's blockbuster has blown a hole in Novo's post-Ozempic ...

Trump increased the rate of a new global tariff to 15 percent, vowing to work around the ruling that invalidated his ...

The Chadster previews tonight's AEW Dynamite from Denver and explains why Tony Khan's show will disrespect WWE and traumatize ...

The leadership imbalance is visible in B.C. Jeanne-Marie Owens, co-founder and COO of Vancouver-based Critical Path Games Ltd ...

A new product from Leaf will feature a variety players from the past, present, and future. And will include relics from late ...